Cancer Connection News

Let's stay connected!

Scan the headlines below and learn about cancer news in your community. Just mouse over the headline; you will find you are just a click away from the latest information from St. Luke's Cancer Center.

St. Luke's Cancer Center Offers Breakthrough Drug for Melanoma

Patients with advanced melanoma may be candidates for a compassionate use trial with the experimental drug ipilimumab (ip-ee-LIM-uh-mab). St. Luke's Cancer Center is the only Hospital in the region to offer this option.

St. Luke's Cancer Expert Publishes Book on Breast Cancer Surgery

Surgical oncologist Dr. Lee Riley and oncology nurse Carol Karchmarsky talk about the steps to take once diagnosed with breast cancer.

Cancer Physician Earns Certification in Quality Oncology Practice Initiative

Anna Niewiarowska, MD, of Vita Medical Associates, PC, has become one of the first oncology practices in the nation to be recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program.

Advanced Surgical Protocols Provide Benefits to Breast Cancer Patients at St. Luke's Hospital

St. Luke's is one of 10 hospitals in Pennsylvania and was one of the first in the state to use MarginMarker® to color-code cancerous breast tissue immediately after surgical removal to see if the entire cancer was remover during the procedure. St. Luke's was the first facility in the region to offer MammaPrint®, an FDA-cleared 70-gene genomic profile that provides information about tumor biology and actively identifies a woman's risk for recurrence.

A Three-Year Accreditation with Commendation is Awarded to St. Luke's Comprehensive Community Cancer Program

The Commission on Cancer (CoC) of the American College of Surgeons (ACoS) has granted Three-Year Accreditation with Commendation to St. Luke's Comprehensive Community Cancer Program. Facilities receive Three-Year Accreditation with Commendation following the onsite evaluation by a physician surveyor during which the facility demonstrates a Commendation level of compliance with one or more standards that represent the full scope of the cancer program (cancer committee leadership, cancer data management, clinical services, research, community outreach and quality improvement).